⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBU News
Caribou Biosciences, Inc. Common Stock
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
globenewswire.com
CRBU
Form 8-K
sec.gov
CRBU
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
CRBU
Watchmaker Genomics verkrijgt licentie voor CRISPR-Cas9-intellectueel eigendom van Caribou Biosciences om de doorvoer te verhogen en de sequencingkosten per monster te verlagen
businesswire.com
CRBU
WGO
Watchmaker Genomics obtient la licence de propriété intellectuelle CRISPR-Cas9 auprès de Caribou Biosciences afin d'augmenter le débit et réduire le coût du séquençage par échantillon
businesswire.com
WGO
CRBU
Watchmaker Genomics lizenziert das geistige Eigentum CRISPR-Cas9 von Caribou Biosciences, um den Durchsatz zu erhöhen und die Sequenzierungskosten pro Probe zu senken
businesswire.com
CRBU
Watchmaker Genomics verkrijgt licentie voor CRISPR-Cas9-intellectueel eigendom van Caribou Biosciences om de doorvoer te verhogen en de sequencingkosten per monster te verlagen
businesswire.com
CRBU
WGO
Watchmaker Genomics lizenziert das geistige Eigentum CRISPR-Cas9 von Caribou Biosciences, um den Durchsatz zu erhöhen und die Sequenzierungskosten pro Probe zu senken
businesswire.com
CRBU
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
businesswire.com
WGO
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
globenewswire.com
CRBU